Safety and efficacy of a new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer in real-world practice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn Y.J. | - |
dc.contributor.author | Yoo S.-Y. | - |
dc.contributor.author | Lee J.-W. | - |
dc.contributor.author | Ahn S.G. | - |
dc.contributor.author | Lee S.-H. | - |
dc.contributor.author | Yoon J. | - |
dc.contributor.author | Park J.H. | - |
dc.contributor.author | Choi W.G. | - |
dc.contributor.author | Cho S. | - |
dc.contributor.author | Lim S.-W. | - |
dc.contributor.author | Jang Y.S. | - |
dc.contributor.author | Kwon K.H. | - |
dc.contributor.author | Lee N.H. | - |
dc.contributor.author | Doh J.H. | - |
dc.contributor.author | Kang W.C. | - |
dc.contributor.author | Jeon D.W. | - |
dc.contributor.author | Lee B.-K. | - |
dc.contributor.author | Heo J.H. | - |
dc.contributor.author | Hong B.-K. | - |
dc.contributor.author | Choi H.-H. | - |
dc.date.available | 2020-04-06T06:43:34Z | - |
dc.date.created | 2020-04-02 | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/26322 | - |
dc.description.abstract | Background and Objectives: Recently, Genoss drug-eluting stent (DES)™ stent comprising cobalt-chromium platform with an ultrathin strut thickness, sirolimus, and an abluminal biodegradable polymer was developed. Owing to the lack of substantial evidence for the safety and efficacy of this stent, we report 12-month results of the Genoss DES™ stent. Methods: We analyzed subjects who were eligible for a 12-month follow-up from the ongoing Genoss DES™ registry, which is a prospective, single-arm, observational, multicenter trial to investigate the clinical outcomes after the successful Genoss DES™ stent implantation among all-comers. The primary endpoint was a device-oriented composite outcome, defined as cardiac death, target vessel-related myocardial infarction, and target lesion revascularization at 12-month follow-up. Results: Among 622 subjects, the mean age of subjects was 66.5±10.4 years, 70.6% were males, 67.5% had hypertension, and 38.3% had diabetes. The implanted stent number, diameter, and length per patient were 1.5±0.8, 3.1±0.4 mm, and 36.0±23.3 mm, respectively. At 12-month clinical follow-up, the primary endpoint occurred only in 4 (0.6%) subjects. Conclusions: The novel Genoss DES™ stent exhibited excellent safety and efficacy in real-world practice. Copyright © 2020. The Korean Society of Cardiology | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Circulation | - |
dc.relation.isPartOf | Korean Circulation Journal | - |
dc.title | Safety and efficacy of a new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer in real-world practice | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000519918700003 | - |
dc.identifier.doi | 10.4070/kcj.2019.0258 | - |
dc.identifier.bibliographicCitation | Korean Circulation Journal, v.50, no.4, pp.317 - 327 | - |
dc.identifier.kciid | ART002566572 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85081632123 | - |
dc.citation.endPage | 327 | - |
dc.citation.startPage | 317 | - |
dc.citation.title | Korean Circulation Journal | - |
dc.citation.volume | 50 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Doh J.H. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Drug-eluting stents | - |
dc.subject.keywordAuthor | Percutaneous coronary intervention | - |
dc.subject.keywordAuthor | Prospective studies | - |
dc.subject.keywordAuthor | Registries | - |
dc.subject.keywordPlus | acetylsalicylic acid | - |
dc.subject.keywordPlus | angiotensin receptor antagonist | - |
dc.subject.keywordPlus | anticoagulant agent | - |
dc.subject.keywordPlus | antivitamin K | - |
dc.subject.keywordPlus | beta adrenergic receptor blocking agent | - |
dc.subject.keywordPlus | calcium channel blocking agent | - |
dc.subject.keywordPlus | cilostazol | - |
dc.subject.keywordPlus | clopidogrel | - |
dc.subject.keywordPlus | dipeptidyl carboxypeptidase inhibitor | - |
dc.subject.keywordPlus | fenofibrate | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase inhibitor | - |
dc.subject.keywordPlus | nicorandil | - |
dc.subject.keywordPlus | nitrate | - |
dc.subject.keywordPlus | polyglactin | - |
dc.subject.keywordPlus | polylactic acid | - |
dc.subject.keywordPlus | prasugrel | - |
dc.subject.keywordPlus | ticagrelor | - |
dc.subject.keywordPlus | acute coronary syndrome | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | calcification | - |
dc.subject.keywordPlus | chronic total occlusion | - |
dc.subject.keywordPlus | clinical outcome | - |
dc.subject.keywordPlus | coronary artery circumflex branch | - |
dc.subject.keywordPlus | coronary artery obstruction | - |
dc.subject.keywordPlus | coronary stenting | - |
dc.subject.keywordPlus | device safety | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | dual antiplatelet therapy | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | heart death | - |
dc.subject.keywordPlus | heart infarction | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypertension | - |
dc.subject.keywordPlus | in-stent restenosis | - |
dc.subject.keywordPlus | intravascular ultrasound | - |
dc.subject.keywordPlus | left anterior descending coronary artery | - |
dc.subject.keywordPlus | left coronary artery | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | multicenter study | - |
dc.subject.keywordPlus | non ST segment elevation myocardial infarction | - |
dc.subject.keywordPlus | observational study | - |
dc.subject.keywordPlus | percutaneous coronary intervention | - |
dc.subject.keywordPlus | prospective study | - |
dc.subject.keywordPlus | right coronary artery | - |
dc.subject.keywordPlus | ST segment elevation myocardial infarction | - |
dc.subject.keywordPlus | stable angina pectoris | - |
dc.subject.keywordPlus | stent thrombosis | - |
dc.subject.keywordPlus | target lesion revascularization | - |
dc.subject.keywordPlus | target vessel revascularization | - |
dc.subject.keywordPlus | thrombectomy | - |
dc.subject.keywordPlus | unstable angina pectoris | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.